Why do you say that?
Enerflex was always there for two distinct roles.
1. the fabrication/production line for Kalina modules.
2. the EPC of the rollout at Saddle Hills.
The only thing i see in the 4C is that (2) will be completed by KDP.
I think this is an excellent strategy as
a. it will increase margins on the project and
b. it gives KDP complete control over the build. They owned the design, the suppliers, now they will control the execution. Very important on this first one to get it perfect. These are experienced power professionals who now can ensure this happens.
This is good news. Negotiations over the EPC contract look like they were the thing holding up financial close on the project. Now that this is sorted out, i see a much more rapid path to FNTP.
The environmental permit looks like a fait a complis now as well. Consultation closes in 27 days. This is all dovetailing nicely.
Choc, you only see negative, yet i bet you didn't sell a single share when the SP ran into the 3s? What a strategy!
- Forums
- ASX - By Stock
- KPO
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KPO (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.459M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 17083025 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 25621397 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 17083025 | 0.003 |
12 | 14531167 | 0.002 |
5 | 7890000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 25621397 | 18 |
0.005 | 6243235 | 5 |
0.006 | 99007 | 1 |
0.007 | 2043125 | 3 |
0.008 | 3100000 | 2 |
Last trade - 16.12pm 15/07/2024 (20 minute delay) ? |
Featured News
KPO (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online